Daniel T. Scavilla, President, CEO at GLOBUS MEDICAL INC (GMED), sold 130,000 shares at $85.00 ($11.1M) on 2024-11-21, disclosed to the SEC on 2024-11-25.
Scheduled sale ($11.1M) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GMED | SELL | 2020-05-26 | $5.5M | — | Filing → |
| GMED | SELL | 2018-04-11 | $5.0M | — | Filing → |